Neil Vasdev Selected Research

Glial Fibrillary Acidic Protein

1/2022

Imaging of astrocytes in posttraumatic stress disorder: A PET study with the monoamine oxidase B radioligand [11C]SL25.1188.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Neil Vasdev Research Topics

Disease

17	Alzheimer Disease (Alzheimer's Disease) 02/2024 - 11/2008
15	Neoplasms (Cancer) 09/2023 - 05/2011
11	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2023 - 01/2017
8	Neuroinflammatory Diseases 12/2022 - 04/2014
7	Major Depressive Disorder (Major Depressive Disorders) 01/2022 - 05/2008
6	Gliosis 11/2023 - 01/2019
5	Breast Neoplasms (Breast Cancer) 03/2015 - 10/2009
4	Tauopathies 02/2024 - 11/2015
4	Parkinson Disease (Parkinson's Disease) 02/2024 - 11/2008
4	Dementia (Dementias) 01/2024 - 04/2014
4	Nervous System Diseases (Neurological Disorders) 01/2023 - 07/2013
4	Inflammation (Inflammations) 01/2022 - 10/2011
3	Chronic Traumatic Encephalopathy 02/2024 - 01/2022
3	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 02/2024 - 11/2015
3	Cognitive Dysfunction 01/2024 - 01/2016
3	Brain Neoplasms (Brain Tumor) 01/2022 - 10/2011
3	Schizophrenia (Dementia Praecox) 01/2020 - 09/2006
3	Brain Diseases (Brain Disorder) 01/2018 - 01/2013
3	Disease Progression 01/2016 - 11/2010
2	Corticobasal Degeneration 02/2024 - 11/2015
2	Lewy Body Disease (Lewy Body Dementia) 02/2024 - 11/2016
2	Multiple Sclerosis 09/2023 - 01/2020
2	Colorectal Neoplasms (Colorectal Cancer) 09/2023 - 01/2022
2	Mental Disorders (Mental Disorder) 01/2023 - 03/2017
2	Brain Injuries (Brain Injury) 01/2023 - 01/2022
2	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2022 - 01/2020
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 04/2021 - 09/2016
2	Atrophy 10/2018 - 01/2017
2	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 10/2018 - 11/2015
2	Lung Neoplasms (Lung Cancer) 01/2017 - 01/2017
2	Pain (Aches) 01/2016 - 07/2013
2	Dehydration (Water Stress) 03/2012 - 01/2011
1	Arthritis (Polyarthritis) 09/2023
1	Infections 09/2023
1	Rodent Diseases 09/2023
1	Autoimmune Diseases (Autoimmune Disease) 09/2023
1	Craniocerebral Trauma (Head Injury) 01/2023
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2023
1	Amyloid Plaque 01/2023
1	Glioblastoma (Glioblastoma Multiforme) 01/2022
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022
1	Circulating Neoplastic Cells 01/2022
1	Carcinogenesis 01/2022
1	Ovarian Neoplasms (Ovarian Cancer) 10/2021

Drug/Important Bio-Agent (IBA)

11	Proteins (Proteins, Gene)FDA Link 02/2024 - 01/2013
9	Biomarkers (Surrogate Marker)IBA 01/2024 - 09/2012
8	Monoamine Oxidase (MAO)IBA 01/2023 - 04/2014
8	EnzymesIBA 05/2021 - 01/2013
6	RadiopharmaceuticalsIBA 01/2024 - 04/2015
6	Glycogen Synthase Kinase 3IBA 01/2023 - 01/2018
5	Amyloid (Amyloid Fibrils)IBA 01/2023 - 11/2015
4	tau Proteins (tau Protein)IBA 01/2023 - 04/2014
4	Glycogen Synthase (Synthase I)IBA 01/2022 - 04/2014
4	7- (6- fluoropyridin- 3- yl)- 5H- pyrido(4,3- b)indoleIBA 01/2021 - 01/2016
4	EndocannabinoidsIBA 01/2020 - 07/2013
4	MetalsIBA 01/2018 - 04/2014
3	SynucleinsIBA 02/2024 - 11/2015
3	Phosphotransferases (Kinase)IBA 01/2023 - 11/2010
3	fatty-acid amide hydrolase (fatty acid amide hydrolase)IBA 01/2020 - 07/2013
2	Agammaglobulinaemia Tyrosine KinaseIBA 09/2023 - 01/2020
2	Celecoxib (Celebrex)FDA Link 01/2022 - 10/2020
2	SL25.1188IBA 01/2022 - 01/2019
2	alantolactoneIBA 04/2021 - 09/2016
2	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2020 - 04/2014
2	DNA-Binding Proteins (DNA Binding Protein)IBA 10/2018 - 11/2015
2	ZincIBA 01/2018 - 09/2015
2	CopperIBA 01/2018 - 09/2015
2	IronIBA 01/2018 - 09/2015
2	IonsIBA 01/2018 - 09/2015
2	Dopamine (Intropin)FDA LinkGeneric 01/2017 - 09/2006
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2017 - 11/2015
2	lorlatinibIBA 01/2017 - 01/2017
2	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 11/2016 - 01/2016
2	anandamide (arachidonylethanolamide)IBA 01/2016 - 07/2013
2	scyllitol (scyllo-inositol)IBA 10/2011 - 10/2009
1	F 4 (F-4)IBA 02/2024
1	Protein Isoforms (Isoforms)IBA 02/2024
1	AMPA Receptors (AMPA Receptor)IBA 01/2024
1	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2024
1	Muscarinic M4 ReceptorIBA 01/2024
1	Glycoproteins (Glycoprotein)IBA 01/2024
1	Vesicular Acetylcholine Transport Proteins (Vesicular Acetylcholine Transporter)IBA 01/2024
1	TritiumIBA 01/2024
1	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 01/2024
1	LipopolysaccharidesIBA 09/2023
1	PalladiumIBA 09/2023
1	evobrutinibIBA 09/2023
1	Serum Amyloid P-ComponentIBA 01/2023
1	DNA (Deoxyribonucleic Acid)IBA 01/2023
1	FructoseIBA 12/2022
1	Death Domain ReceptorsIBA 01/2022
1	Selegiline (E250)FDA LinkGeneric 01/2022
1	HydrogelsIBA 01/2022
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2022
1	Glial Fibrillary Acidic ProteinIBA 01/2022
1	PF-04802367IBA 01/2022
1	11C-PS13IBA 10/2021
1	Ketoprofen (Orudis)FDA LinkGeneric 10/2021

Therapy/Procedure

14	Therapeutics 01/2024 - 09/2006
2	Drug Therapy (Chemotherapy) 01/2017 - 09/2016